HELEN Kurincic is an experienced company director with more than 20 years of governance experience across ASX listed, private, not-for-profit and member-based organisations.
Helen has significant expertise in strategy, risk and governance leadership in regulated sectors.
Helen is currently the Chair of McMillan Shakespeare (ASX:MMS), a salary packaging, novated leasing, asset management and disability plan management business, and is a Non-Executive Director and Member of the Audit Committee at Ramsay Health Care (ASX:RHC) which is a major healthcare provider operating in Australia, Europe and the UK.
Until recently she was also the Chair of medical diagnostic imaging company Integral Diagnostics (ASX:IDX) for nine years, and a Non-Executive Director and Chair of the Risk Committee for both Estia Health and HBF Health.
Helen previously held various executive and non-executive roles, successfully driving business growth and transformation of services.
She started her career as a nurse at the Royal Melbourne Hospital specialising in intensive care, completed a MBA and has attended various courses at Harvard Business School (Best Practice Leadership Program and Business Innovations in Global Healthcare). She also completed the University of Cambridge Institute for Sustainability Leadership Non-Executive Director Program.
Helen is a Fellow of the Australian Institute of Company Directors, Fellow of the Governance Institute of Australia and a Member of Chief Executive Women. She is also a Minerva Network Mentor helping to support Australia’s leading sportswomen.
